Omeprazole Sandoz

Omeprazole, the active ingredient in Omeprazole Sandoz, is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid secretion and is used to treat conditions such as gastro‑esophageal reflux disease, peptic ulcer disease and Zollinger‑Ellison syndrome in adults.

GNH USA supplies Omeprazole Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and regulatory requirements across all markets.

Omeprazole is a proton pump inhibitor that reduces gastric acid production, making it effective for several acid‑related gastrointestinal conditions.

- Gastro‑esophageal reflux disease (GERD): reduces reflux symptoms and promotes healing of esophageal irritation. - Peptic ulcer disease: facilitates ulcer healing and prevents recurrence. - Zollinger‑Ellison syndrome: controls gastric acid hypersecretion associated with gastrin‑producing tumors.

Omeprazole may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools occurring intermittently. - Nausea: occasional feeling of queasiness. - Abdominal pain: discomfort in the stomach area. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis risk. - Severe allergic reactions (anaphylaxis): rash, swelling, breathing difficulty. - Stevens‑Johnson syndrome: rare skin and mucous membrane disorder. - Elevated liver enzymes: potential hepatic injury. - Hypomagnesemia: low magnesium levels with prolonged use. - Increased risk of bone fractures: especially with long‑term therapy.

When prescribing Omeprazole, clinicians should consider several precautionary measures to ensure safe use.

- Renal function: assess in patients with severe kidney disease. - Hepatic impairment: dose adjustment may be required. - Concomitant medications: review for potential interactions. - Elderly patients: monitor for increased fracture risk. - Long‑term therapy: evaluate need periodically. - Store at room temperature: keep in original container, protect from moisture.

Omeprazole can affect the pharmacokinetics of several medicines; interactions are categorized by clinical significance.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect. - Atazanavir: decreased absorption and efficacy. - HIV protease inhibitors (e.g., ritonavir): altered plasma levels.

Moderate Interactions (Monitor Closely): - Digoxin: increased serum concentrations. - Rifampin: decreased omeprazole exposure.